Results 51 to 60 of about 5,063 (199)
Emerging Paediatric Uses of Dupilumab Beyond Approvals
Dupilumab, through IL‐4Rα blockade, shows promising efficacy beyond approved indications in paediatric diseases driven by T2 inflammation. Emerging evidence—mainly from small studies—supports improvements in disease severity and quality of life, highlighting its potential as a targeted, steroid‐sparing therapy while underscoring the need for ...
Simone Foti Randazzese +11 more
wiley +1 more source
Prevalence of Prurigo Nodularis in Poland
Prurigo nodularis is a chronic skin condition that presents significant challenges for treatment and quality of life, with little known about disease prevalence. This study assessed the prevalence of prurigo nodularis in Poland using publicly maintained database case records and diagnostic codes for prurigo nodularis (L28.1) and other prurigo (L28.2 ...
RYCZEK, Anna, REICH, Adam
openaire +3 more sources
Taoming Liu, Juan Bai, Su Wang, Shuni Ying, Sheng Li, Jianjun Qiao, Hong Fang Department of Dermatology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, People’s Republic of ChinaCorrespondence: Jianjun Qiao; Hong ...
Liu T +6 more
doaj
A Case Report of Prurigo Nodularis-Like Lesions in a Patient with Lepromatous Leprosy
Leprosy or Hansen’s disease is a chronic granulomatous infection that primarily affects the peripheral nerves and, consequently, the skin. Clinical manifestations vary from hypopigmentation to erythematous plaques, and it can present with leonine facies.
Siwanon Nawalerspanya +2 more
doaj +1 more source
PDE4 Inhibition in Dermatologic Disease: Impacts Beyond Inflammation
This graphical abstract demonstrates the comprehensive mechanism of PDE4 inhibition in skin physiology. By increasing intracellular cAMP and activating PKA, PDE4 inhibitors exert pleiotropic effects, including immune modulation, pigmentation regulation, barrier enhancement, sensory neuron modulation, and improved wound healing with reduced fibrosis ...
Keana Khodadad +2 more
wiley +1 more source
Supplemental material, Table S1, for Systemic Medication for the Treatment of Prurigo Nodularis—A Systematic Review by Lillian E. McCampbell, Mallory L. Zaino, Manas Ranpariya, Tejesh Patel and Steven R.
Steven R. Feldman (8598421) +4 more
core +1 more source
Dupilumab‐Induced Psoriasis in a Patient with Bullous Pemphigoid
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Nina Matthes +6 more
wiley +1 more source
Successful Treatment of Severe Adult Linear IgA Dermatosis Using Dupilumab
ABSTRACT Linear IgA dermatosis (LAD) is a rare autoimmune subepidermal bullous dermatosis, characterised by the presence of erythematous vesiculobullous lesions arranged in rosettes or herpetiform clusters. The standard treatment involves the administration of dapsone, followed by sulfasalazine, and general corticosteroid therapy, often in combination ...
Célia Delesalle +7 more
wiley +1 more source
Health-related quality of life and economic burden of prurigo nodularis: Supplemental Data
Supplemental tables for article entitled 'Health-related quality of life and economic burden of prurigo nodularis', published in Journal of American Academy of ...
Whang, K (via Mendeley Data) +1 more
core +1 more source
Prurigo nodularis in a young child with a parasitic infestation with Ascaris lumbricoides
Prurigo nodularis is a chronic dermatosis of uncertain etiology, clinically characterized by itchy nodules occurring on the extensor aspect of the limbs.
D. Boccardi +3 more
core +1 more source

